Table 2 Distribution of LTRs in Active promoters in malignant, immortalized, primary and embryonic stem cells.
From: VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer
| Â | Cell Type | Total Promoters | Total Promoters that overlap LTRs | % of Total Promoters that overlap LTRs | Cell-line Specific Promoters | % Cell-line Specific Promoters | Cell-line Specific Promoters that overlap LTRs | % of Cell line Specific Promoters that overlap LTRs | Number of LTRs that overlaps cell-line specific Promoters |
|---|---|---|---|---|---|---|---|---|---|
K562 | Malignant | 15,627 | 1,199 | 7.7% | 1,599 | 10.2% | 427 | 26.7% | 622 |
HepG2 | Malignant | 15,993 | 1,165 | 7.3% | 1,886 | 11.8% | 303 | 16.1% | 400 |
GM12878 | Immortalized | 15,279 | 989 | 6.5% | 1,613 | 10.6% | 153 | 9.5% | 203 |
NHLF | Primary | 14,888 | 546 | 3.7% | 259 | 1.7% | 15 | 5.8% | 16 |
HMEC | Primary | 13,711 | 535 | 3.9% | 145 | 1.1% | 9 | 6.2% | 12 |
HSMM | Primary | 14,335 | 537 | 3.7% | 305 | 2.1% | 23 | 7.5% | 25 |
HUVEC | Primary | 12,319 | 397 | 3.2% | 102 | 0.8% | 6 | 5.9% | 7 |
NHEK | Primary | 14,009 | 700 | 5.0% | 219 | 1.6% | 24 | 11.0% | 29 |
H1-hESC | Embryonic Stem | 12,477 | 568 | 4.6% | 453 | 3.6% | 217 | 47.9% | 308 |